Affinities of venlafaxine and various reuptake inhibitors for the serotonin and norepinephrine transporters

被引:88
作者
Béïque, JC [1 ]
Lavoie, N [1 ]
de Montigny, C [1 ]
Debonnel, G [1 ]
机构
[1] McGill Univ, Neurobiol Psychiat Unit, Montreal, PQ H3A 1A1, Canada
基金
英国医学研究理事会;
关键词
antidepressant; 5-HT; (5-hydroxytryptamine; 5-HT); transporter; norepinephrine transporter; duloxetine; binding;
D O I
10.1016/S0014-2999(98)00241-6
中图分类号
R9 [药学];
学科分类号
1007 ;
摘要
In vitro radioligand binding studies were carried out in rat brain membranes to assess the affinity of various reuptake inhibitors for the serotonin (5-hydroxytryptamine, 5-HT) and the norepinephrine transporters using the selective ligands [H-3]cyanoimipramine and [H-3]nisoxetine, respectively. The selective 5-HT reuptake inhibitors paroxetine, indalpine and fluvoxamine displayed a high affinity for the 5-HT transporter, whereas the norepinephrine reuptake inhibitor desipramine had a high affinity for the norepinephrine transporter. Duloxetine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed a high affinity for both the 5-HT and the norepinephrine transporters. Interestingly, venlafaxine, a dual 5-HT and norepinephrine reuptake inhibitor, displayed only a moderate affinity for the 5-HT transporter (K-i = 74 nM) and a very low affinity for the norepinephrine transporter (K-i = 1.26 mu M). The relatively low affinities of venlafaxine contrast with its potent in vivo 5-HT and norepinephrine reuptake blocking properties. These results raise the possibility that the in vivo effects on the 5-HT and norepinephrine reuptake observed with venlafaxine may not be mediated solely by its binding to the [H-3]cyanoimipramine and [H-3]nisoxetine binding sites. (C) 1998 Elsevier Science B.V. All rights reserved.
引用
收藏
页码:129 / 132
页数:4
相关论文
共 15 条
[1]  
Beique J. C., 1996, Society for Neuroscience Abstracts, V22, P180
[2]   CURRENT ADVANCES AND TRENDS IN THE TREATMENT OF DEPRESSION [J].
BLIER, P ;
DEMONTIGNY, C .
TRENDS IN PHARMACOLOGICAL SCIENCES, 1994, 15 (07) :220-226
[3]   BLOCKADE BY NEWLY-DEVELOPED ANTIDEPRESSANTS OF BIOGENIC-AMINE UPTAKE INTO RAT-BRAIN SYNAPTOSOMES [J].
BOLDENWATSON, C ;
RICHELSON, E .
LIFE SCIENCES, 1993, 52 (12) :1023-1029
[5]   [H-3]nisoxetine - A radioligand for noradrenaline reuptake sites: Correlation with inhibition of [H-3]noradrenaline uptake and effect of DSP-4 lesioning and antidepressant treatments [J].
Cheetham, SC ;
Viggers, JA ;
Butler, SA ;
Prow, MR ;
Heal, DJ .
NEUROPHARMACOLOGY, 1996, 35 (01) :63-70
[6]  
DEMONTIGNY C, 1996, ACNP 34 ANN M, P158
[7]   A double-blind comparison of venlafaxine and fluoxetine for treatment of major depression in outpatients [J].
Dierick, M ;
Ravizza, L ;
Realini, R ;
Martin, A .
PROGRESS IN NEURO-PSYCHOPHARMACOLOGY & BIOLOGICAL PSYCHIATRY, 1996, 20 (01) :57-71
[8]  
DUMBRILLEROSS A, 1983, MOL PHARMACOL, V23, P607
[9]  
GEHLERT DR, 1995, J NEUROCHEM, V64, P2792
[10]  
Kasamo K, 1996, J PHARMACOL EXP THER, V277, P278